Vol. 45 | No. 1 | January-June 2017 Back

Open Access

Compliance with In-Patient Performance Measures in the Management of Heart Failure Patients at the Manila Doctors Hospital

April Ann A. Bermudez, Allan A. Lim, Felix Eduardo R. Punzalan, Noemi S. Pestano
Jun 2017 DOI 10.69944/pjc.673311830a

Abstract

Background: Heart failure (HF) is a growing public health problem, with a prevalence of 0.5% to 6.7% in Southeast  Asian countries. Previous studies have shown that compliance with guidelines and performance measures decreases the rates of mortality and rehospitalization for HF. This study evaluated the adherence to in-patient measures of HF management at the Manila Doctors Hospital. 

Study design: This was a retrospective cross-sectional study that involved HF patients admitted at the Manila  Doctors Hospital from September 2013 to September 2014. The following performance measure sets were computed based on data from patient records: compliance with left ventricular systolic function (LVSF) assessment; beta-blocker (BB) therapy for left ventricular systolic dysfunction (LVSD); angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) therapy for LVSD; and post-discharge follow-up appointment rate.  

Results: Seventy-seven patients were included in the study. Their mean age was 63±15 years. Seventy-one  patients (92.2%) underwent echocardiographic assessment. The overall mean ejection fraction was 39.4±14.5%. For patients with HF with preserved ejection fraction, the mean ejection fraction was 59.4 ± 6.9%. For patients with HF with reduced ejection fraction, the mean ejection fraction was 28.4 ± 6.1%. Left ventricular ejection fraction assessment was done in 93.5%. In patients with LVSD, 82.5% received BB therapy (evidence-based BB, 78.7%), while ACEI/ARB therapy was given in 87.5%. All patients who were discharged were given follow-up appointments. 

Conclusion: Based on the present data, the compliance of physicians of Manila Doctors Hospital to measures of  care in HF management is at par with current international and local data. 

Keywords: heart failure, preserved ejection fraction, reduced ejection fraction, performance measure compliance.

References
  1. Hung YT, et al. Epidemiology of heart failure in Hong Kong, 1997.  HKMJ 2000; 6:159-62 
  2. Chong AY, et al. Heart failure in a multiethnic population in  Kuala Lumpur, Malaysia. The European Journal of Heart Failure.  2003;5:569-574. 
  3. Jorge J, et al. The DEAR Heart Program: the profile of the Filipino  adult symptomatic heart failure patients based on the data derived  from pilot phase of the D.E.A.R. Heart program from Nov 1, 2002  to Dec 31, 2004. The National Heart Failure Registry Program  (hospital-based). PJC. 2007. 35(1): 32-43. 
  4. Bonow RO, et al. ACCF/AHA/AMA-PCPI 2011 performance  measures for adults with heart failure: a report of the American College  of Cardiology Foundation/American Heart Association Task Force  on performance measures and the American Medical Association Physician Consortium for performance improvement. Circulation.  2012; 125:2382-2401. 
  5. Bonow RO, et al. ACC/AHA clinical performance measures for  adults with chronic heart failure: a report of the American College of  Cardiology / American Heart Association Task Force on performance  measures (writing committee to develop heart failure clinical  performance measures): endorsed by the Heart Failure Society of  America. Circulation. 2005; 112:1853-1887. 
  6. Bonow RO, et al. American College of Cardiology Foundation/  American Heart Association/ Physician Consortium for Performance  Improvement Heart Failure Performance Measurement Set. Available  at: http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/hfset-12-5.pdf. Accessed June 25, 2014 
  7. Mann DL., Zipes DP, et al. Braunwald’s heart disease: a textbook  of cardiovascular medicine. 10th ed. 2014. 27:557-574. Elsevier  Saunders, Philadelphia. 
  8. Chin H, et al. 2009 Focused Update Incorporated Into the ACC/ AHA 2005 Guidelines for the Diagnosis and Management of Heart  Failure in Adults: A Report of the American College of Cardiology  Foundation/American Heart Association Task Force on Practice  Guidelines: Developed in Collaboration With the International  Society for Heart and Lung Transplantation. Circulation. 2009;  119:e391-e479. 
  9. Krumholz HM, et.al. ACC/AHA 2008 Performance Measures for  Adults With ST-Elevation and Non− ST-Elevation Myocardial  Infarction : A Report of the American College of Cardiology/ American Heart Association Task Force on Performance Measures  (Writing Committee to Develop Performance Measures for  ST-Elevation and Non−ST-Elevation Myocardial Infarction).  Circulation. 2008;118:2596-2648 
  10. Bonow RO, et al. ACC/AHA Classification of care metrics:  performance measures and quality metrics. A report of the American  College of Cardiology / American Heart Association Task Force on  Performance Measures. JACC. 2008;52(24):2113-7 
  11. AHA/ACC Conference Proceedings: Measuring and improving  quality of care. A report from the American Heart Association/ American College of Cardiology first scientific forum on assessment  of health care quality in cardiovascular disease and stroke. Circulation.  2000;101:1483-1493. 
  12. Yancy CW, Lopatin M, et al. Clinical presentation, management and  in-hospital outcomes of patients admitted with acute decompensated  heart failure with preserved systolic function. A report from the  Acute Decompensated Heart Failure National Registry (ADHERE)  database. J Am Coll Cardiol. 2006;47:76-84. (13) 
  13. Misa DO. Profile of patients hospitalized for acute decompensated  heart with preserved left ventricular fraction. Philippine Heart Center  Journal. 2007. 13(1):62 (Abstract). (14) 
  14. Spertus JA, et al. American College of Cardiology and American  Heart Association methodology for the selection and creation of  performance measures for quantifying the quality of cardiovascular  care. Circulation. 2005; 111:1703-1712. 
  15. CIBIS Investigators and Committees. A Randomized Trial Of Beta Blockade In Heart Failure: the Cardiac Insufficiency Bisoprolol Study  (CIBIS). Circulation 1994;90:1765- 73. 
  16. Fagerberg B, et al. Effect of metoprolol CR/XL in chronic heart  failure: metoprolol CR/XL randomised intervention trial in congestive  heart failure. The Lancet. 1999. 353(9169):2001-7 
  17. Hjalmarson A, et al. Effects Of Controlled-Release Metoprolol on  Total Mortality, Hospitalizations, And Well-Being In Patients With  Heart Failure: the Metoprolol CR/XL Randomized Intervention Trial  in Congestive Heart Failure (MERIT-HF). JAMA 2000;283:1295-302. 
  18. Dargie HJ, et al. The Cardiac Insufficiency Bisoprolol Study II  (CIBIS-II): A Randomised Trial. Lancet 1999;353:9-13. 19. Hernandez AF, et al. Clinical effectiveness of beta-blockers in heart  failure: findings from the OPTIMIZE-HF (Organized Program to  Initiate Lifesaving Treatment in Hospitalized Patients with Heart  Failure) Registry. J Am Coll Cardiol. 2009 Jan 13;53(2):184-92. 
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.